Personalis

Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.

In January, Personalis made the decision to slash its workforce by approximately 30% and took other measures, including closing their facility in China, that should chop payroll and other expenses by an estimated $20 million annually.

Over the years, Personalis has worked with several companies by providing genomic test information about the patient's cancer so that a personalized vaccine could be developed specifically for each individual patient.

Prelude Capital Management LLC purchased a new stake in Personalis in the 2nd quarter worth approximately $35,000.

This isn't just about technology; it's about giving patients and their families a clearer path forward in their fight against cancer," said Chris Hall, President and CEO of Personalis.

A hedge fund recently bought a new stake in Personalis stock.

Baum adds, “She genuinely cares about the mission at Saint Louis University and Cura Personalis.